Inventor · disambiguated record
Vincent John Wacher
Also filed as: WACHER VINCENT · WACHER VINCENT J · WACHER VINCENT JOHN
14 granted patents·4 pending applications·556 citations·filing 1995–2024
93Inventor score
Files withAVMAX INC5SYNTHETIC BIOLOGICS INC5THERIVA BIOLOGICS INC4ANMAX INC1CEDARS SINAI MEDICAL CENTER1
Top patents by PatentIndex Score
18 records- 0194US5716928AUse of essential oils to increase bioavailability of oral pharmaceutical compoundsAVMAX INC·Filed 1995·Granted Feb 10, 1998·194 cites·40 claims
- 0291US9744221B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2015·Granted Aug 29, 2017·3 cites·12 claims
- 0389US5665386AUse of essential oils to increase bioavailability of oral pharmaceutical compoundsAVMAX INC·Filed 1995·Granted Sep 9, 1997·114 cites·10 claims
- 0488US6121234AUse of essential oils to increase bioavailability of orally administered pharmaceutical compoundsAVMAX INC·Filed 1998·Granted Sep 19, 2000·88 cites·18 claims
- 0587US10987410B2Alkaline phosphatase formulationsSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Apr 27, 2021·3 cites·6 claims
- 0687US2024197842A1Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 0786US11944669B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsTHERIVA BIOLOGICS INC·Filed 2023·Granted Apr 2, 2024·0 cites·19 claims
- 0883US10046035B2Methods and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2017·Granted Aug 14, 2018·2 cites·12 claims
- 0983US5962522APropyl gallate to increase bioavailability of orally administered pharmaceutical compoundsAVMAX INC·Filed 1997·Granted Oct 5, 1999·69 cites·23 claims
- 1082US12508304B2Alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·14 claims
- 1181US6180666B1Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compoundsANMAX INC·Filed 1999·Granted Jan 30, 2001·69 cites·54 claims
- 1274US11596674B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGIES INC·Filed 2020·Granted Mar 7, 2023·0 cites·19 claims
- 1373US10792346B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Oct 6, 2020·0 cites·16 claims
- 1471US12048735B2Alkaline phosphatase formulationsTHERIVA BIOLOGICS INC·Filed 2021·Granted Jul 30, 2024·0 cites·7 claims
- 1550US5916566AUse of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compoundsAVMAX INC·Filed 1996·Granted Jun 29, 1999·14 cites·7 claims
- 1650US2003215462A1Use of UGT inhibitors to increase bioavailabilityFiled 2002·Application pending·0 cites
- 1746US2020390742A1Clinically efficacious anti-methanogenic compositions and usesCEDARS SINAI MEDICAL CENTER·Filed 2017·Application pending·0 cites
- 1840US2019277833A1Anti-methanogenic compositionsSYNTHETIC BIOLOGICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vincent John Wacher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →